Positive Response to New Neoadjuvant Treatment Combination for Gastric and Gastroesophageal Cancer Despite advances in treatment options, most patients diagnosed with non-metastatic((cancer that has not yet spread to other organs) gastric or […]

Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA) What is CCA? Cholangiocarcinoma (CCA) is a cancer that starts in the biliary tract. The biliary tract includes the liver, gallbladder and bile […]

COR2ED’s New Resources on Advanced HCC COR2ED is an independent medical education company that develops impactful educational programmes within specific therapeutic areas. They have […]

WECAN Evidence-Based Advocacy Workshop From 17-19 January, Lāsma Nikolaisone, a patient advocate from “Onkoalianse”, a member organisation of Digestive Cancers Europe in Latvia, had the […]

Lynch Syndrome, the Most Common of the Rarest 22 March is Lynch Syndrome Day, also known as Hereditary Non-Polyposis Colorectal Cancer, so we will remind people that those who have Lynch […]

ASCO GI Highlights – Positive Data in Earlier Stage HCC Results The American Society for Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) was held in San Francisco, USA 18-20 January this year. At […]

Gemcitabine Plus Paclitaxel vs Gemcitabine Alone after FOLFIRINOX in Metastatic Pancreatic Cancer GEMPAX was an open-label (both researchers and patients know which treatment is being administered), randomised (randomly assigns participants i […]

European Union Steps Up its Efforts to Eliminate Liver Cancer The European Commission presented Recommendations to support Members States in their efforts to prevent cancer through vaccination, it is a part of […]

Celebrating a Lifetime of Achievement: Dr Eric Van Cutsem Honoured as Professor Emeritus Dr Eric Van Cutsem, world-renowned Professor of Clinical Digestive Oncology and co-founder of Digestive Cancers Europe, was lauded as Professor […]

Educational Booklets For Togas Pilot Studies Participants Are Now Available Gastric cancer is the fourth most common cause of cancer-related deaths worldwide and is the fifth most frequently diagnosed cancer. It accounts for […]

Act4Biosimilars: The Action Plan and Deep Dive Report for Europe are Now Live! Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater Approvability, Accessibility, […]

F2F Consortium Meeting in Madrid The GUIDE.MRD (Guiding multi-modal therapies against MRD by liquid biopsies) consortium partners met for the first face-to-face annual meeting […]

EuropaColon Portugal Launched Support Line for Carers The data from the Caring for Informal Carers Movement surveys show that there are many issues facing these carers in Portugal, but one gap that s […]

DiCE Participants Complete Patient Expert Training We are thrilled to announce that two participants from Digestive Cancers Europe (DiCE) completed the EUPATI Patient Expert Training Programme in […]

New Expert Advisor on CRC Screening We are delighted to welcome Dr. Carlo Senore as our new advisor for colorectal cancer screening. Dr. Senore brings a wealth of expertise to our […]

Understanding Metastatic Colorectal Cancer: A Call to Awareness on World Metastatic Colorectal Cancer Day

DiCE Supports MOs Training Opportunity As an integral part of our commitment to patient care, we are pleased to inform you that DiCE will award two grants to DiCE Full members who are […]

Economist Impact: World Cancer Series Europe On 20 September, the Belgian delegation of the DiCE Team attended the Economist Impact’s World Cancer Series: Europe in Brussels, proudly supporting […]

Do You Dare to Think Differently about Cancer?